Navigation Links
Deciphering the body's healing secrets
Date:2/12/2009

Healthy blood vessels play a key role in the prevention and treatment of diseases such as cardiovascular disease and diabetes.

Endothelial cells line the blood vessels and are critical to the regulation of blood vessel growth and function.

Researchers at the Centenary Institute have discovered a mechanism that helps control the development of endothelial cells.

Professor Jenny Gamble, Head of the Vascular Biology program at Centenary, says the process by which endothelial progenitor cells (EPCs) change to mature endothelial cells is an important but little understood control.

"If endothelial cell lining is injured or damaged, for example during wound healing, an organ transplant or heart attack, the EPC leave the bone marrow, circulate in the blood and home to the site of the injury where they continue to repair and are induced to become mature cells," she explains.

Publishing in Blood, Professor Gamble and her team found that this process, called differentiation, is partly controlled by the enzyme sphingosine kinase-1.

"We found that high levels of SK-1 keep the cells as EPCs whereas a decrease in the amount of SK-1 allows the cell to differentiate to functionally mature endothelial cells."

By understanding these fundamental tools the body uses to heal itself, there is potential to manipulate this process to create new treatments.

For example, the vascular complications of diabetes are attributed, in part, to the decreased numbers and function of EPCs. Additionally, stents are used extensively for the treatment of cardiovascular disease. However they can often be problematic because of a lack of good endothelial cell coverage.

Centenary Institute Executive Director, Professor Mathew Vadas says an increased understanding of the process of differentiation may allow SK-1 to be manipulated to drive this process and therefore improve treatments of these diseases in the
'/>"/>

Contact: Erin Sharp
e.sharp@centenary.org.au
61-295-656-118
Research Australia
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Deciphering the Language of Intoxication
2. Swelling After Knee Injury May Hinder Healing
3. Data from Patient Subsets of e-HEALING, a Worldwide Registry, Support Use of OrbusNeichs Genous(TM) Bio-Engineered R Stent(TM) as Alternative to Drug- Eluting Stents
4. Retired NYPD Lieutenants William E. Keegan, Jr., Owen McCaffery and John Moran and Tom Thees, a former COO in the financial industry, announce today the formation of H.E.A.R.T (Healing Emergency Aid Response Team) 911.
5. Cleveland Clinic Press Releases Journal-Writing Book Write for Life: Healing Body, Mind, and Spirit Through Journal Writing by Sheppard B. Kominars, Ph.D.
6. LOreal Paris Celebrates Ten Years of Hope and Healing
7. Newer Antibiotic Speeds TB Healing
8. The Well Life Center in Mesa Unveils The 10 Healing Secrets to Health & Longevity Lecture. Proceeds Benefit The Arizona Special Olympics
9. PEAK Surgical Announces Positive Surgical Incision Wound Healing Results With the PEAK PlasmaBlade(TM)
10. The Well Life Center in Mesa Continues The 10 Healing Secrets to Health & Longevity Lecture. Proceeds Benefit The Arizona Special Olympics
11. The Healing Power of Green
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine News(10 mins):Health News:Pharmacyclics, Inc. Announces Presentation of Interim Results From Phase I Trial of Its First-In-Human Btk Inhibitor PCI-32765 2Health News:Pharmacyclics, Inc. Announces Presentation of Interim Results From Phase I Trial of Its First-In-Human Btk Inhibitor PCI-32765 3Health News:Pharmacyclics, Inc. Announces Presentation of Interim Results From Phase I Trial of Its First-In-Human Btk Inhibitor PCI-32765 4Health News:Pharmacyclics, Inc. Announces Presentation of Interim Results From Phase I Trial of Its First-In-Human Btk Inhibitor PCI-32765 5Health News:City of Hope Researchers Present Data on more than 30 Studies During American Society of Hematology Meeting Dec. 5 to 8 in New Orleans 2Health News:City of Hope Researchers Present Data on more than 30 Studies During American Society of Hematology Meeting Dec. 5 to 8 in New Orleans 3Health News:City of Hope Researchers Present Data on more than 30 Studies During American Society of Hematology Meeting Dec. 5 to 8 in New Orleans 4Health News:City of Hope Researchers Present Data on more than 30 Studies During American Society of Hematology Meeting Dec. 5 to 8 in New Orleans 5Health News:VitaminSpice Signs Agreement With Former CEO of Wal-Mart Stores Division for US Distribution 2Health News:Data Published in Leading Respiratory Journal Reinforce Importance of Small Airways In Asthma Management 2Health News:Data Published in Leading Respiratory Journal Reinforce Importance of Small Airways In Asthma Management 3Health News:Data Published in Leading Respiratory Journal Reinforce Importance of Small Airways In Asthma Management 4Health News:Data Published in Leading Respiratory Journal Reinforce Importance of Small Airways In Asthma Management 5Health News:New approach to sickle-cell disease shows promise in mice 2
Breaking Medicine Technology:CareFusion Announces Six New Pyxis(R) Technologies at the ASHP Midyear Clinical Meeting and Exhibition 2CareFusion Announces Six New Pyxis(R) Technologies at the ASHP Midyear Clinical Meeting and Exhibition 3The Epilepsy Research Foundation and Milken Family Foundation Announce Prestigious Translational Research Grants for Two Pioneering Epilepsy Therapies 2The Epilepsy Research Foundation and Milken Family Foundation Announce Prestigious Translational Research Grants for Two Pioneering Epilepsy Therapies 3The Epilepsy Research Foundation and Milken Family Foundation Announce Prestigious Translational Research Grants for Two Pioneering Epilepsy Therapies 4The Epilepsy Research Foundation and Milken Family Foundation Announce Prestigious Translational Research Grants for Two Pioneering Epilepsy Therapies 5Baxa Features DoseEdge(TM) Pharmacy Workflow Manager at the ASHP Midyear Clinical Meeting 2Baxa Features DoseEdge(TM) Pharmacy Workflow Manager at the ASHP Midyear Clinical Meeting 3InterMune Announces Submission of NDA for Pirfenidone for the Treatment of Patients with IPF 5979 1InterMune Announces Submission of NDA for Pirfenidone for the Treatment of Patients with IPF 5979 2InterMune Announces Submission of NDA for Pirfenidone for the Treatment of Patients with IPF 5979 3InterMune Announces Submission of NDA for Pirfenidone for the Treatment of Patients with IPF 5979 4BioMarin to Present at the Credit Suisse Healthcare Conference 5975 1BioMarin to Present at the Credit Suisse Healthcare Conference 5975 2Spectros Signs New International Distribution Deals 10635 1Spectros Signs New International Distribution Deals 10635 2